MPX Bioceutical Corporation (OTC: MPXEF) announced on September 19th it has officially entered into an agreement to purchase all outstanding shares of Spartan. The purchase agreement for Spartan consists of a $4,500,000 issuance in MPX common shares and $1,500,000 in common share purchase warrants of MPX.
The Spartan organization is primarily focused on the rehabilitation of veterans with dependencies on opioids through the usage medicinal cannabis. Spartan’s patient network consists of 500 patients that use nearly 500kgs in medical cannabis per year.
MPX plans to distribute to the patient network MPX and Salus Medical products.